Transvaginal ultrasonography and endometrial changes in postmenopausal breast cancer patients receiving tamoxifen
- 31 August 1996
- Vol. 25 (1) , 45-50
- https://doi.org/10.1016/0378-5122(96)01043-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Long-term prognosis of breast cancer: An analysis of 462 patients in a general hospital in south east NetherlandsEuropean Journal of Surgical Oncology, 1995
- Transvaginal ultrasonography for identifying endometrial pathology in postmenopausal womenMaturitas, 1994
- Gynaecological monitoring during tamoxifen therapyThe Lancet, 1994
- Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trialThe Lancet, 1994
- Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *JNCI Journal of the National Cancer Institute, 1994
- Endometrial Changes with Tamoxifen: Comparison between Tamoxifen-Treated and Nontreated Asymptomatic, Postmenopausal Breast Cancer PatientsGynecologic Oncology, 1994
- Risk of endometrial cancer after tamoxifen treatment of breast cancerThe Lancet, 1994
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Correlation of ultrasound findings and endometrial histopathology in postmenopausal womenBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989